Published in Dent Today on May 01, 2016
Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem (2004) 1.67
The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation. Diabetes (2009) 1.32
Prostate cancer risk assessment program: a 10-year update of cancer detection. J Urol (2007) 1.28
Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. J Am Soc Nephrol (2006) 1.24
An Australian casemix classification for palliative care: lessons and policy implications of a national study. Palliat Med (2004) 1.08
Cardiac magnetic resonance T2 mapping in the monitoring and follow-up of acute cardiac transplant rejection: a pilot study. Circ Cardiovasc Imaging (2012) 1.03
The last drag: an evaluation of an LGBT-specific smoking intervention. J Homosex (2012) 0.99
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia. J Med Chem (2011) 0.97
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant (2005) 0.97
The development of Version 2 of the AN-SNAP casemix classification system. Aust Health Rev (2007) 0.95
Transport and deposition of sediment-associated Escherichia coli in natural streams. Water Res (2005) 0.94
An Australian casemix classification for palliative care: technical development and results. Palliat Med (2004) 0.93
Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species. Eur J Pharmacol (2007) 0.92
Clinical specialists and advanced practitioners in physical therapy: a survey of physical therapists and employers of physical therapists in ontario, Canada. Physiother Can (2008) 0.91
Time-dependent clearance of mycophenolic acid in renal transplant recipients. Br J Clin Pharmacol (2007) 0.88
Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus. Arthritis Rheum (2013) 0.86
Comparison between two classes of selective EP(3) antagonists and their biological activities. Bioorg Med Chem Lett (2006) 0.85
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists. Bioorg Med Chem Lett (2011) 0.85
Health services research and development in practice: an Australian experience. J Health Serv Res Policy (2003) 0.85
Complex HeartMate II infection treated with pump exchange to HeartWare HVAD. ASAIO J (2013) 0.85
Traumatic shoulder injuries: a force mechanism analysis-glenohumeral dislocation and instability. AJR Am J Roentgenol (2013) 0.84
Structure-activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP(3) antagonists. Bioorg Med Chem Lett (2005) 0.84
Characterization of platelet-derived growth factor-C (PDGF-C): expression in normal and tumor cells, biological activity and chromosomal localization. Int J Biochem Cell Biol (2002) 0.83
Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors. Bioorg Med Chem Lett (2010) 0.83
Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study. Clin Cancer Res (2003) 0.81
Pyridazinones as selective cyclooxygenase-2 inhibitors. Bioorg Med Chem Lett (2003) 0.78
Improving operating theatre communication between the orthopaedics surgeon and radiographer. ANZ J Surg (2013) 0.78
3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility. Bioorg Med Chem Lett (2003) 0.78
Findings From the National Machine Guarding Program: A Small Business Intervention: Lockout/Tagout. J Occup Environ Med (2016) 0.77
The development of potent non-peptidic PTP-1B inhibitors. Bioorg Med Chem Lett (2004) 0.76
Guidelines for the practice and performance of manipulation under anesthesia. Chiropr Man Therap (2014) 0.75
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. Transplantation (2017) 0.75
Findings From the National Machine Guarding Program-A Small Business Intervention: Machine Safety. J Occup Environ Med (2016) 0.75
Sense and Sensibility When Prescribing 'Off-Label' to Psychiatric Patients. Curr Pharm Des (2015) 0.75
Hemolysis and pump failure secondary to spontaneous bend relief disconnection in a HeartMate II device with a sealed outlet graft. J Heart Lung Transplant (2012) 0.75
Assessment of denitrification gaseous end-products in the soil profile under two water table management practices using repeated measures analysis. J Environ Qual (2005) 0.75
Bacterial Pathogen Indicator Transport from Livestock Mortality Biopiles. J Environ Qual (2015) 0.75
Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile. Bioorg Med Chem Lett (2002) 0.75
Modeling E.coli fate and transport in treatment wetlands using the water quality analysis and simulation program. J Environ Sci Health A Tox Hazard Subst Environ Eng (2011) 0.75
Traumatic shoulder injuries: a force mechanism analysis of complex injuries to the shoulder girdle and proximal humerus. AJR Am J Roentgenol (2013) 0.75
Findings From the National Machine Guarding Program: Safety Climate, Hazard Assessment, and Safety Leadership in Small Metal Fabrication Businesses. J Occup Environ Med (2017) 0.75
The right to refuse treatment: Commonwealth developments and issues. Int J Law Psychiatry (1983) 0.75